Publications Publications Genomics as a Clinical Decision Support Tool for Identifying and Addressing Modifiable Causes of Cognitive Decline and Improving Outcomes: Proof of Concept Support for This Personalized Medicine Strategy Publications The landscape of therapeutics for mild cognitive impairment and dementia is quite limited. While many single-agent trials of pharmaceuticals have been conducted, these trials have repeatedly been unable to show improvement in cognition. Genomics as a Clinical Decision Support Tool White Paper Considerable evidence is emerging that Autism Spectrum Disorder (ASD) is most often triggered by a range of different genetic variants that interact with environmental factors such as exposures to toxicants and changes to the food supply. Utilizing Genomically Targeted Molecular Data to Improve Patient-Specific Outcomes in Autism Spectrum Disorder White Paper Molecular biology combined with genomics can be a powerful tool for developing potential intervention strategies for improving outcomes in children with autism spectrum disorders (ASD). Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project Effective therapeutics for Alzheimer’s disease are needed. However, previous clinical trials have pre-determined a single treatment modality, such as a drug candidate or therapeutic procedure, which may be unrelated to the primary drivers of the neurodegenerative process. Journal of the American College of Nutrition White Paper Personalized Nutrition: Translating the Science of NutriGenomics Into Practice: Proceedings From the 2018 American College of Nutrition Meeting Journal of the American College of Nutrition White Paper Genomics of Detoxification: How Genomics can be Used for Targeting Potential Intervention and Prevention Strategies Including Nutrition for Environmentally Acquired Illness Journal of Alzheimers Disease & Parkinsonism White Paper Reversal of Cognitive Decline: 100 Patients Press and Media IntellxxDNA Powers Groundbreaking Child Health Study Alongside Documenting Hope IntellxxDNA™, a leader in genomic insights, is thrilled to announce a partnership with Documenting Hope, the research arm of Epidemic Answers, a 501(c)(3) nonprofit dedicated to helping children heal from chronic health conditions. IntellxxDNA’s Innovative Memory and Genomics Decision-Making Tool Study Gains IRB Approval IntellxxDNA™ stands as a leader, offering actionable genomic insights that can help prevent and reverse the symptoms of cognitive decline through precision genomic medicine.
Genomics as a Clinical Decision Support Tool for Identifying and Addressing Modifiable Causes of Cognitive Decline and Improving Outcomes: Proof of Concept Support for This Personalized Medicine Strategy Publications The landscape of therapeutics for mild cognitive impairment and dementia is quite limited. While many single-agent trials of pharmaceuticals have been conducted, these trials have repeatedly been unable to show improvement in cognition.
Genomics as a Clinical Decision Support Tool White Paper Considerable evidence is emerging that Autism Spectrum Disorder (ASD) is most often triggered by a range of different genetic variants that interact with environmental factors such as exposures to toxicants and changes to the food supply.
Utilizing Genomically Targeted Molecular Data to Improve Patient-Specific Outcomes in Autism Spectrum Disorder White Paper Molecular biology combined with genomics can be a powerful tool for developing potential intervention strategies for improving outcomes in children with autism spectrum disorders (ASD).
Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project Effective therapeutics for Alzheimer’s disease are needed. However, previous clinical trials have pre-determined a single treatment modality, such as a drug candidate or therapeutic procedure, which may be unrelated to the primary drivers of the neurodegenerative process.
Journal of the American College of Nutrition White Paper Personalized Nutrition: Translating the Science of NutriGenomics Into Practice: Proceedings From the 2018 American College of Nutrition Meeting
Journal of the American College of Nutrition White Paper Genomics of Detoxification: How Genomics can be Used for Targeting Potential Intervention and Prevention Strategies Including Nutrition for Environmentally Acquired Illness
IntellxxDNA Powers Groundbreaking Child Health Study Alongside Documenting Hope IntellxxDNA™, a leader in genomic insights, is thrilled to announce a partnership with Documenting Hope, the research arm of Epidemic Answers, a 501(c)(3) nonprofit dedicated to helping children heal from chronic health conditions.
IntellxxDNA’s Innovative Memory and Genomics Decision-Making Tool Study Gains IRB Approval IntellxxDNA™ stands as a leader, offering actionable genomic insights that can help prevent and reverse the symptoms of cognitive decline through precision genomic medicine.
